The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: Development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia

被引:39
|
作者
Skinner M.W. [1 ]
Chai-Adisaksopha C. [2 ,10 ]
Curtis R. [3 ]
Frick N. [4 ]
Nichol M. [5 ]
Noone D. [6 ]
O'Mahony B. [6 ,7 ]
Page D. [8 ]
Stonebraker J.S. [9 ]
Iorio A. [2 ,10 ]
机构
[1] Institute for Policy Advancement Ltd, 1155 23rd Street NW #3A, Washington, 20037, DC
[2] McMaster University, Department of Medicine, Hamilton
[3] Factor VIII Computing, Berkeley
[4] National Hemophilia Foundation, New York
[5] University of Southern California, Sol Price School of Public Policy, Los Angeles
[6] Irish Haemophilia Society, Dublin
[7] Trinity College Dublin, Dublin
[8] Canadian Hemophilia Society, Montreal
[9] North Carolina State University, Poole College of Management, Raleigh
[10] McMaster University, Department of Health Research Methods, Evidence, and Impact, Hamilton
关键词
Haemophilia; Patient-centered research; Patient-reported outcomes; Quality of life;
D O I
10.1186/s40814-018-0253-0
中图分类号
学科分类号
摘要
Background: The interest of health care agencies, private payers and policy makers for patient-reported outcomes (PRO) is continuously increasing. There is a substantial need to improve capacity to collect and interpret relevant PRO data to support implementation of patient-centered research and optimal care in haemophilia. The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project aims to develop a patient-led research network, to develop a standardized questionnaire to gather patient-reported outcomes and to perform a feasibility study of implementing the PROBE questionnaire. Methods: A pilot questionnaire was developed using focus group methodology. Content and face validity were assessed by a pool of persons living with haemophilia (PWH) and content experts through interactive workshops. The PROBE questionnaire was translated with the forward-backward approach. PROBE recruited national haemophilia patient non-governmental organizations (NGOs) to administer the questionnaire to people with and without haemophilia. PROBE measured the time to complete the questionnaire and gathered feedback on its content and clarity; staff time and cost required to implement the questionnaire were also collected. Results: The PROBE questionnaire is comprised of four major sections (demographic data, general health problems, haemophilia-related health problems and health-related quality of life using EQ-5D-5L and EQ-VAS). Seventeen NGOs participated in the pilot study of the PROBE Project, recruiting 656 participants. Of these, 71% completed the questionnaire within 15 min, and all participants completed within 30 min. The median total staff and volunteer time required for the NGOs to carry out the study within their country was 9 h (range 2 to 40 h). NGO costs ranged from $22.00 to $543.00 USD per country, with printing and postage being the most commonly reported expenditures. Conclusions: The PROBE questionnaire assesses patient-important reported outcomes in PWH and control participants, with a demonstrated short completion time. PROBE proved the feasibility to engage diverse patient communities in the structured generation of real-world outcome research at all stages. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [31] Patient perspective of quality. patient-reported outcomes vs physician reported outcomes
    Kirchheiner, K.
    Nout, R. A.
    Tanderup, K.
    Lindegaard, J. C.
    Doerr, W.
    Poetter, R.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S70 - S71
  • [32] Evaluating patient reported outcomes and experiences in a novel proton beam clinic – challenges, activities, and outcomes of the ProtonCare project
    K Sjövall
    U Langegård
    P Fransson
    E Nevo-Ohlsson
    I Kristensen
    K Ahlberg
    B Johansson
    BMC Cancer, 23
  • [33] Evaluating patient reported outcomes and experiences in a novel proton beam clinic - challenges, activities, and outcomes of the ProtonCare project
    Sjoevall, K.
    Langegard, U.
    Fransson, P.
    Nevo-Ohlsson, E.
    Kristensen, I
    Ahlberg, K.
    Johansson, B.
    BMC CANCER, 2023, 23 (01)
  • [34] Patient-reported outcomes and patient voices
    Asci, Gulay
    Ok, Ercan
    SEMINARS IN DIALYSIS, 2022, 35 (05) : 457 - 458
  • [35] Patient copayments and patient-reported outcomes
    Mullins, CD
    CLINICAL THERAPEUTICS, 2002, 24 (04) : 674 - 674
  • [36] NAPPA - Development and Validation of a Questionnaire to Collect patient-reported Outcomes in Nail psoriasis
    Augustin, M.
    Blome, C.
    Michaelis-Wittern, K.
    Radtke, M.
    Reich, K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 227 - 227
  • [37] 'The patient': at the center of patient-reported outcomes
    Awad, A. George
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (05) : 729 - 731
  • [38] PATIENT REPORTED OUTCOMES IN BREAST CANCER: DEVELOPMENT AND VALIDATION OF A NOVEL AND CLINICALLY USEFUL QUESTIONNAIRE
    Medhurst, Kerensa
    Howard, Fuchsia
    Koulis, Theodora
    Dosani, Maryam
    Dahinten, Susan
    Willinsky, Paul
    Olson, Robert
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S58 - S58
  • [39] Development of the Ulcerative Colitis Patient-Reported Outcomes (UC-PRO) Questionnaire
    Higgins, Peter D.
    Harding, Gale
    Patrick, Donald L.
    Revicki, Dennis A.
    Globe, Gary
    Viswanathan, Hema N.
    Trease, Sarah
    Fitzgerald, Kristina
    Borie, Dominique C.
    Leidy, Nancy K.
    GASTROENTEROLOGY, 2013, 144 (05) : S768 - S768
  • [40] Patient-reported outcomes in drug safety evaluation
    Basch, E.
    ANNALS OF ONCOLOGY, 2009, 20 (12) : 1905 - 1906